CLINICAL_TRIALS
withdrawal
· 2024-11-29
Clinical Trial Update: MSD Belzutifan PAS
Summary
The belzutifan trial for von Hippel-Lindau disease has been withdrawn.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Merck Sharp & Dohme LLC | Conditions: Von Hippel Lindau Disease | Status: WITHDRAWN